Lymphedema involves the accumulation of lymph fluid in fatty tissues just beneath the skin. The condition is caused due to impaired flow in the lymphatic system of a person and is observed either in the legs or arms or in both of them. It can also affect the abdomen, neck, genitals, and face of a person, depending on the portion of the body which has undergone treatment. Primary lymphedema is generally present at birth, while secondary lymphedema is caused due to dysfunction or damage to the lymphatic system. Cancer-related treatment is a prominent cause of secondary lymphedema. Surgery, radiation therapy, or cancer itself can hinder the flow of lymph fluid, leading to lymphedema. Symptoms of lymphedema include feeling of tightness or heaviness; swelling in the legs, arms, or other parts of the body; ache or discomfort; and fibrosis, which means thickening or hardening of the skin.
Rise in the number of lymphedema cases globally is a prominent factor driving the growth of the global lymphedema treatment market. According to some estimates, 140-250 million people across the globe are affected by lymphedema. In the U.S., around 1-2 million people suffer from primary lymphedema, while 2-3 million are affected with secondary lymphedema. Rise in incidence of cancer, especially breast cancer, is another factor boosting the number of lymphedema cases globally. Patients undergoing radiation therapy or surgery for breast cancer treatment are at a high risk of developing lymphedema. Breast cancer is the most commonly observed cancer among women and is the second-most common type of cancer. According to the World Cancer Research Fund, an estimated 2 million cases of breast cancer were reported in 2018 across the world.
Launch of new medical devices by companies is another factor contributing to the growth of the global lymphedema treatment market. In May 2017, Tactile Systems Technology, Inc., a prominent manufacturer of at-home therapy devices, announced the launch of Flexitouch system in the U.S. market. Flexitouch system is a pneumatic compression device for use in the treatment of lymphedma of neck and head. The device, which was granted approval by the U.S. Food and Drug Administration (FDA) in September 2016, is the only pneumatic compression system that can deliver non-invasive therapy to patients and can help in stimulating their lymphatic system.
Ongoing research for the development of novel therapies for the treatment of lymphedema is another driver of the global lymphedema treatment market. According to a new study conducted at the Stanford University School of Medicine, a new molecular mechanism primarily responsible for causing lymphedema, along with a drug (bestatin) which has the potential for hindering the process, was uncovered in May 2017. Bestatin is currently undergoing clinical trials for the treatment of secondary lymphedema. Positive outcome from the trials is expected to be a step forward toward developing new treatment option for the management of lymphedema.
The global lymphedema treatment market can be segmented based on treatment type, end-user, and region. In terms of treatment type, the market can be classified into surgery, compression therapy, and others. Based on end-user, the lymphedema treatment market can be divided into hospitals, clinics, and others.
In terms of geography, the global lymphedema treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global lymphedema treatment market due to launch of new products for the management of the condition. North America is followed by Europe and Asia Pacific in terms of dominance over the global lymphedema treatment market. In Asia Pacific, increasing incidence of breast cancer is likely to fuel the growth of the lymphedema treatment market during the forecast period.
Prominent players operating in the global lymphedema treatment market include Bio Compression Systems, Inc., BSN medical, Lohmann & Rauscher, Mego Afek ltd, SIGVARIS, and Tactile Systems Technology Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.